← Leaderboards
Pamela Fitch Weiss
Children'S Hosp Of Philadelphia
$3,661,080
Attributed
$3,661,080
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $599.2K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,661,080 · 6
By mechanism
R01$2,212,644 · 2
K23$609,798 · 1
K24$530,860 · 1
R03$219,528 · 1
F32$88,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Razzaghi Hanieh$555,151
- Matthew C. Hocking$3,520,475
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationChildChildhoodArthritisAccountingChronic Childhood ArthritisPreventInflammatoryPredictive ValuePharmaceutical PreparationsAdultJointsSacroiliac Joint StructureMorbidity - Disease RateDiagnosisAdolescentImageRecording Of Previous EventsFutureRheumatologyDisease RemissionAnkylosing SpondylitisCohortClinical Trials
Grant awards (22)
Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis$364,553
R01 · FY2025 · AR · contact PI
Mentoring and Patient Oriented Research in Juvenile Spondyloarthritis$132,715
K24 · FY2025 · AR · contact PI
Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis$377,034
R01 · FY2024 · AR · contact PI
Mentoring and Patient Oriented Research in Juvenile Spondyloarthritis$132,715
K24 · FY2024 · AR · contact PI
Mentoring and Patient Oriented Research in Juvenile Spondyloarthritis$132,715
K24 · FY2023 · AR · contact PI
Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis$382,026
R01 · FY2022 · AR · contact PI
Mentoring and Patient Oriented Research in Juvenile Spondyloarthritis$132,715
K24 · FY2022 · AR · contact PI
Immunological, serologic, and imaging biomarker predictors of flare in pediatric spondyloarthritis$411,417
R01 · FY2021 · AR · contact PI
Refining entry criteria and outcome measures for children with axial disease and spondyloarthritis: preparation for clinical trials$187,792
R01 · FY2021 · AR · contact PI
Refining entry criteria and outcome measures for children with axial disease and spondyloarthritis: preparation for clinical trials$186,634
R01 · FY2020 · AR · contact PI
Refining entry criteria and outcome measures for children with axial disease and spondyloarthritis: preparation for clinical trials$303,188
R01 · FY2019 · AR · contact PI
Evaluation and treatment of enthesitis-related arthritis$116,450
K23 · FY2015 · AR · contact PI
Evaluation and treatment of enthesitis-related arthritis$116,450
K23 · FY2014 · AR · contact PI
Sacroiliitis in early ERA$82,075
R03 · FY2014 · AR · contact PI
Evaluation and treatment of enthesitis-related arthritis$515
K23 · FY2014 · AR · contact PI
Evaluation and treatment of enthesitis-related arthritis$125,577
K23 · FY2013 · AR · contact PI
Sacroiliitis in early ERA$68,178
R03 · FY2013 · AR · contact PI
Evaluation and treatment of enthesitis-related arthritis$125,505
K23 · FY2012 · AR · contact PI
Sacroiliitis in early ERA$69,275
R03 · FY2012 · AR · contact PI
Evaluation and treatment of enthesitis-related arthritis$125,301
K23 · FY2011 · AR · contact PI
Henoch Schonlein Purpura and Corticosteroid Treatment$20,041
F32 · FY2008 · DK · contact PI
Henoch Schonlein Purpura and Corticosteroid Treatment$68,209
F32 · FY2007 · DK · contact PI